Published in CMAJ on August 05, 2003
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14
Measurements of acute cerebral infarction: a clinical examination scale. Stroke (1989) 14.54
Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke (1997) 3.94
Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke (1997) 2.83
Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology (1997) 2.77
Assessment of scales of disability and handicap for stroke patients. Stroke (1991) 2.36
Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke (1997) 1.88
Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Can J Neurol Sci (2001) 1.53
The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry (1990) 1.31
Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES). CASES Investigators. Can J Neurol Sci (2001) 1.08
Determinants of handicap 1 and 3 years after a stroke. Disabil Rehabil (1997) 0.87
Baseline measures and outcome predictions. Neuroepidemiology (1994) 0.82
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Weekends: a dangerous time for having a stroke? Stroke (2007) 4.47
Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem (2004) 3.57
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev (2010) 2.70
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
Changing perspectives regarding late-life dementia. Nat Rev Neurol (2009) 2.04
Escalating levels of access to in-hospital care and stroke mortality. Stroke (2008) 1.97
Barriers to telemedicine: survey of current users in acute care units. Telemed J E Health (2011) 1.94
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. J Med Chem (2002) 1.92
Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res (2004) 1.89
Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA (2004) 1.85
Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc (2003) 1.80
MRI detects white matter reorganization after neural progenitor cell treatment of stroke. Neuroimage (2006) 1.69
Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol (2012) 1.68
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke (2009) 1.63
Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke (2003) 1.63
Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol (2011) 1.63
Does a birthday predispose to vascular events? Neurology (2006) 1.62
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60
Hyperdense internal carotid artery sign: a CT sign of acute ischemia. Stroke (2008) 1.56
Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke (2008) 1.51
Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke (2005) 1.48
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47
Thrombolysis in patients with marked clinical fluctuations in neurologic status due to cerebral ischemia. Arch Neurol (2008) 1.47
Vascular risk factors and Alzheimer's disease. Expert Rev Neurother (2008) 1.47
Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke (2007) 1.46
Cerebral ischemic events associated with 'bubble study' for identification of right to left shunts. Stroke (2009) 1.44
World Stroke Day 2008: "little strokes, big trouble". Stroke (2008) 1.42
Diabetes, intracranial stenosis and microemboli in asymptomatic carotid stenosis. Can J Neurol Sci (2013) 1.41
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Cryptogenic stroke and atrial fibrillation. N Engl J Med (2014) 1.41
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41
Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis. J Am Soc Nephrol (2009) 1.40
Treatment of acute stroke with recombinant tissue plasminogen activator and abciximab. Acad Emerg Med (2003) 1.40
Reporting clinical trials: full access to all of the data. Arch Neurol (2002) 1.39
Hypertension, executive dysfunction, and progression to dementia: the canadian study of health and aging. Arch Neurol (2010) 1.32
Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation (2011) 1.30
Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J Med Chem (2007) 1.30
Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol (2009) 1.30
Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist (2009) 1.29
A 10-year follow-up of urinary and fecal incontinence among the oldest old in the community: the Canadian Study of Health and Aging. Can J Aging (2004) 1.25
Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med (2008) 1.20
Cellular senescence, vascular disease, and aging: Part 1 of a 2-part review. Circulation (2011) 1.17
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke (2005) 1.17
Stroke: the next 30 years. Stroke (2002) 1.14
Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS. Nucl Med Biol (2005) 1.14
Moyamoya syndrome associated with Graves' disease: a case report and review of the literature. J Stroke Cerebrovasc Dis (2010) 1.13
Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology (2005) 1.12
The state of emergency stroke resources and care in rural Arizona: a platform for telemedicine. Telemed J E Health (2009) 1.12
Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc (2009) 1.12
Endovascular therapy for ischemic stroke. N Engl J Med (2015) 1.10
Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms. Dalton Trans (2011) 1.10
Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives. Circ Cardiovasc Qual Outcomes (2012) 1.09
Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res (2006) 1.09
Motor cortex and gait in mild cognitive impairment: a magnetic resonance spectroscopy and volumetric imaging study. Brain (2013) 1.07
Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis (2008) 1.07
Telemedicine versus telephone for remote emergency stroke consultations: a critically appraised topic. Neurologist (2009) 1.06
Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke (2009) 1.05
Cerebral cortical processing of swallowing in older adults. Exp Brain Res (2006) 1.04
Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke (2005) 1.03
A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applications. Dalton Trans (2009) 1.03
Impact of disability status on ischemic stroke costs in Canada in the first year. Can J Neurol Sci (2012) 1.01
Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed. Stroke (2007) 1.01
Cardiac complications in acute ischemic stroke. West J Emerg Med (2011) 1.01
Socioeconomic status, hospital volume, and stroke fatality in Canada. Stroke (2008) 1.00
The population approach to stroke prevention: a Canadian perspective. Clin Invest Med (2003) 1.00
The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles. Dalton Trans (2007) 1.00
Idiopathic free-floating thrombus of the common carotid artery. Can J Neurol Sci (2002) 0.99
Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders? Neurologist (2007) 0.98
Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke (2011) 0.98
Antihypertensive treatment can prevent stroke and cognitive decline. Nat Rev Neurol (2012) 0.97
Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist (2009) 0.97
Alzheimer's disease with and without cerebral infarcts. J Neurol Sci (2004) 0.97
Inside or outside a ligand cleft? Synthetic, structural, and kinetic inertness studies of zinc, cadmium, and mercury complexes of cross-bridged cyclam and cyclen. Dalton Trans (2004) 0.97
Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program. Stroke (2009) 0.96
The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement (2006) 0.95
Neglecting the difference: does right or left matter in stroke outcome after thrombolysis? Stroke (2006) 0.94
Carotid endarterectomy for ophthalmic manifestations: what do we do? J Neuroophthalmol (2005) 0.94
A systematic review of telestroke. Postgrad Med (2013) 0.94
Clinical predictors of psychogenic nonepileptic seizures: a critically appraised topic. Neurologist (2008) 0.93
Comprehensive cardiac rehabilitation for secondary prevention after transient ischemic attack or mild stroke: I: feasibility and risk factors. Stroke (2011) 0.92
Therapeutic benefit of internet-based lifestyle counselling for hypertension. Can J Cardiol (2012) 0.92
Vitamin D concentration and lateral cerebral ventricle volume in older adults. Mol Nutr Food Res (2012) 0.92
Systematic review of teleneurology: methodology. Front Neurol (2012) 0.92
Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci (2008) 0.92
Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis (2009) 0.91
Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies. Neurohospitalist (2011) 0.90
Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topic. Neurologist (2012) 0.90
Forearm compartment syndrome following intravenous thrombolytic therapy for acute ischemic stroke. Neurocrit Care (2005) 0.90
Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experience. Stroke (2012) 0.90